Skip to main content
SNAP Update and Resources Actualización y recursos de SNAP

On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more

El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más

Transportation Update Actualización de transporte

SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.

Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.

Learn more

SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.

Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.

Obtenga más información AQUI

Clinical Prior Authorization Criteria Updates

Date: December 16, 2024

Attention: Providers

Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that the Texas Health and Human Services (HHSC) has updated multiple clinical prior authorization criteria guides. 

How this impacts providers: HHSC reviewed the following clinical prior authorization criteria guides and made updates. The list of revisions is on available on Navitus page.

The following drug categories are impacted:

  • ADD/ADHD
  • Aliskiren-Containing Agents
  • Antimigraine-Triptans
  • Appetite Suppressant Agents
  • Buprenorphine Agents
  • CGRP Antagonists, Prophylaxis
  • CNS Stimulants
  • Cortisol Receptor Antagonists
  • Cytokine and CAM Antagonists
  • Diclofenac Topical
  • DDP-4 Inhibitors
  • Duplicate Therapy
  • Erthropoiesis-Stimulating Factors
  • Evrysdi
  • Fentanyl Agents
  • Gabapentin Agents
  • GI Motility Agents
  • Growth Hormone Agents
  • HP Acthar
  • Immunomodulator Agents for Dry Eye
  • Inhaled Antibiotics
  • Lupus Agents
  • Monoclonal Antibody Agents
  • Opiate Overutilization
  • Opiate/Benzodiazepine/Muscle Relaxant Combinations
  • Oxycodone Extended-Release Agent
  • Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
  • Voxogo

Next step for Providers: Providers should visit the Navitus page to become familiar with the changes and share this information with their staff. 

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org

For access to all provider alerts: https://www.texaschildrenshealthplan.org/provideralerts